Description: The purpose of this survey is to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, as compared to prior period baseline mortality results. The datasets for this report encompass all Group Term Life claims reported to participating carriers as of August 31, 2020. The Committee is grateful that 20 of the top 21 U.S. Group Term Life insurers are participating in this survey, with market share representing roughly 90% of the industry.

Description: The purpose of this survey is to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, as compared to prior period baseline mortality results. The datasets for this report encompass all Group Term Life claims reported to participating carriers as of August 31, 2020. The Committee is grateful that 20 of the top 21 U.S. Group Term Life insurers are participating in this survey, with market share representing roughly 90% of the industry.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through March 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in December 2020, which contained data through August 2020.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through March 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in December 2020, which contained data through August 2020.

Description: U.S. population death statistics and trends often occupy COVID-19 briefings and daily headlines. There are also publicly available mortality data sources for actuaries and others to perform their own analysis. Yet industry studies examining the impact of COVID-19 on insured populations are in their infancy. In this webcast, presenters will provide insights into how the life insured population is faring during COVID-19 by discussing the findings from two recent SOA research initiatives. LIMRA, RGA Reinsurance, the Society of Actuaries and TAI have collaborated on an effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA has surveyed insurers to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic and comparing them to pre-pandemic mortality levels.

Description: The Mortality Improvement Survey Subcommittee of the Society's Committee on Life Insurance Mortality & Underwriting Surveys has completed its report on the results of a survey to examine mortality improvement practices with respect to life insurance pricing in both the US and Canada. A few questions were asked about functions other than pricing.

Description: April 13, 2021 Presentation at 2021 Life Insurance Conference

Description: As part of its ongoing effort to provide useful information on COVID-19, the Society of Actuaries issued a brief survey to its Investment Section members to gain insight as to how COVID-19 is impacting investment professionals. The survey results are intended to help members compare their thinking and future expectations of COVID-19 with their peers.

Description: The Mortality Improvement Survey Subcommittee of the Society's Committee on Life Insurance Mortality & Underwriting Surveys has completed its report on the results of a survey to examine mortality improvement practices with respect to reinsurance pricing in both the US and Canada. A few questions were asked about functions other than pricing.

Description: As part of its ongoing effort to provide useful information on COVID-19, the Society of Actuaries issued a brief survey to its Investment Section members to gain insight as to how COVID-19 is impacting investment professionals. The survey results are intended to help members compare their thinking and future expectations of COVID-19 with their peers.